BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

458 related articles for article (PubMed ID: 23884036)

  • 21. A Korean patient with glutaric aciduria type 1 with a novel mutation in the glutaryl CoA dehydrogenase gene.
    Kim HS; Yu HJ; Lee J; Park HD; Kim JH; Shin HJ; Jin DK; Lee M
    Ann Clin Lab Sci; 2014; 44(2):213-6. PubMed ID: 24795062
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Macrocephaly as the initial manifestation of glutaryl-CoA-dehydrogenase deficiency (glutaric aciduria type I)].
    Trefz FK; Hoffmann GF; Mayatepek E; Lichter-Konecki U; Weisser J; Otten A; Wendel U; Rating D; Bremer HJ
    Monatsschr Kinderheilkd; 1991 Nov; 139(11):754-8. PubMed ID: 1775140
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutic modulation of cerebral L-lysine metabolism in a mouse model for glutaric aciduria type I.
    Sauer SW; Opp S; Hoffmann GF; Koeller DM; Okun JG; Kölker S
    Brain; 2011 Jan; 134(Pt 1):157-70. PubMed ID: 20923787
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Complex heterogeneity phenotypes and genotypes of glutaric aciduria type 1].
    Wang Q; Yang YL
    Zhongguo Dang Dai Er Ke Za Zhi; 2016 May; 18(5):460-5. PubMed ID: 27165598
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glutaric acidemia type 1: outcomes before and after expanded newborn screening.
    Viau K; Ernst SL; Vanzo RJ; Botto LD; Pasquali M; Longo N
    Mol Genet Metab; 2012 Aug; 106(4):430-8. PubMed ID: 22728054
    [TBL] [Abstract][Full Text] [Related]  

  • 26. (1)H-MRS in glutaric aciduria type 1: impact of biochemical phenotype and age on the cerebral accumulation of neurotoxic metabolites.
    Harting I; Boy N; Heringer J; Seitz A; Bendszus M; Pouwels PJ; Kölker S
    J Inherit Metab Dis; 2015 Sep; 38(5):829-38. PubMed ID: 25860816
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduction of Na+, K+-ATPase activity and expression in cerebral cortex of glutaryl-CoA dehydrogenase deficient mice: a possible mechanism for brain injury in glutaric aciduria type I.
    Amaral AU; Seminotti B; Cecatto C; Fernandes CG; Busanello EN; Zanatta Â; Kist LW; Bogo MR; de Souza DO; Woontner M; Goodman S; Koeller DM; Wajner M
    Mol Genet Metab; 2012 Nov; 107(3):375-82. PubMed ID: 22999741
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intracerebral accumulation of glutaric and 3-hydroxyglutaric acids secondary to limited flux across the blood-brain barrier constitute a biochemical risk factor for neurodegeneration in glutaryl-CoA dehydrogenase deficiency.
    Sauer SW; Okun JG; Fricker G; Mahringer A; Müller I; Crnic LR; Mühlhausen C; Hoffmann GF; Hörster F; Goodman SI; Harding CO; Koeller DM; Kölker S
    J Neurochem; 2006 May; 97(3):899-910. PubMed ID: 16573641
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glutaric aciduria types I and II.
    Gordon N
    Brain Dev; 2006 Apr; 28(3):136-40. PubMed ID: 16368216
    [TBL] [Abstract][Full Text] [Related]  

  • 30. l-Carnitine prevents oxidative stress in striatum of glutaryl-CoA dehydrogenase deficient mice submitted to lysine overload.
    Guerreiro G; Amaral AU; Ribeiro RT; Faverzani J; Groehs AC; Sitta A; Deon M; Wajner M; Vargas CR
    Biochim Biophys Acta Mol Basis Dis; 2019 Sep; 1865(9):2420-2427. PubMed ID: 31181292
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Higher Vulnerability of Menadione-Exposed Cortical Astrocytes of Glutaryl-CoA Dehydrogenase Deficient Mice to Oxidative Stress, Mitochondrial Dysfunction, and Cell Death: Implications for the Neurodegeneration in Glutaric Aciduria Type I.
    Rodrigues MDN; Seminotti B; Zanatta Â; de Mello Gonçalves A; Bellaver B; Amaral AU; Quincozes-Santos A; Goodman SI; Woontner M; Souza DO; Wajner M
    Mol Neurobiol; 2017 Aug; 54(6):4795-4805. PubMed ID: 27510504
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glutaric aciduria type I: outcome of patients with early- versus late-diagnosis.
    Couce ML; López-Suárez O; Bóveda MD; Castiñeiras DE; Cocho JA; García-Villoria J; Castro-Gago M; Fraga JM; Ribes A
    Eur J Paediatr Neurol; 2013 Jul; 17(4):383-9. PubMed ID: 23395213
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interaction of glutaric aciduria type 1-related glutaryl-CoA dehydrogenase with mitochondrial matrix proteins.
    Schmiesing J; Schlüter H; Ullrich K; Braulke T; Mühlhausen C
    PLoS One; 2014; 9(2):e87715. PubMed ID: 24498361
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The M405V allele of the glutaryl-CoA dehydrogenase gene is an important marker for glutaric aciduria type I (GA-I) low excretors.
    Schillaci LA; Greene CL; Strovel E; Rispoli-Joines J; Spector E; Woontner M; Scharer G; Enns GM; Gallagher R; Zinn AB; McCandless SE; Hoppel CL; Goodman SI; Bedoyan JK
    Mol Genet Metab; 2016 Sep; 119(1-2):50-6. PubMed ID: 27397597
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Type 1 glutaric aciduria: clinical and therapeutic implications].
    Jiménez Caballero PE; Marsal Alonso C
    Neurologia; 2007 Jun; 22(5):329-32. PubMed ID: 17508309
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Teaching NeuroImages: Glutaric aciduria type 1 (glutaryl-CoA dehydrogenase deficiency).
    Singh P; Goraya JS; Ahluwalia A; Saggar K
    Neurology; 2011 Jul; 77(1):e6. PubMed ID: 21727264
    [No Abstract]   [Full Text] [Related]  

  • 37. Clinical course, early diagnosis, treatment, and prevention of disease in glutaryl-CoA dehydrogenase deficiency.
    Hoffmann GF; Athanassopoulos S; Burlina AB; Duran M; de Klerk JB; Lehnert W; Leonard JV; Monavari AA; Müller E; Muntau AC; Naughten ER; Plecko-Starting B; Superti-Furga A; Zschocke J; Christensen E
    Neuropediatrics; 1996 Jun; 27(3):115-23. PubMed ID: 8837070
    [TBL] [Abstract][Full Text] [Related]  

  • 38. COVID-19 triggered encephalopathic crisis in a patient with glutaric aciduria type 1.
    Zubarioglu T; Ahmadzada S; Yalcinkaya C; Kiykim E; Aktuglu-Zeybek C
    J Pediatr Endocrinol Metab; 2021 Dec; 34(12):1611-1614. PubMed ID: 34517439
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inherited Disorders of Lysine Metabolism: A Review.
    Bouchereau J; Schiff M
    J Nutr; 2020 Oct; 150(Suppl 1):2556S-2560S. PubMed ID: 33000154
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Complementary dietary treatment using lysine-free, arginine-fortified amino acid supplements in glutaric aciduria type I - A decade of experience.
    Kölker S; Boy SP; Heringer J; Müller E; Maier EM; Ensenauer R; Mühlhausen C; Schlune A; Greenberg CR; Koeller DM; Hoffmann GF; Haege G; Burgard P
    Mol Genet Metab; 2012 Sep; 107(1-2):72-80. PubMed ID: 22520952
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.